Genedx leadership
WebAWS certified, Azure expert skilled in several grid engines, highly parallel storage, continuous integration / continuous development, and Agile … WebJan 18, 2024 · GeneDx’s leadership in rare disease diagnostic and exome sequencing services brings more than 300,000 clinical exomes and over 2.1 million expertly annotated phenotypes to strengthen Sema4’s 12...
Genedx leadership
Did you know?
WebApr 3, 2024 · As a member of the executive leadership team, Devin will report directly to Katherine Stueland, President and CEO, and will be responsible for all legal, compliance, and regulatory activities for GeneDx. “We’re so happy to have Devin join the team. WebMay 2, 2024 · STAMFORD, Conn., May 02, 2024 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today …
WebGeneDx announced yesterday that Devin Schaffer has been appointed as General Counsel, effective April 24, 2024. Having held multiple … WebWith over 20 years of experience in clinical genetic testing, 400,000+ clinically sequenced exomes, and our leading clinical and genomic interpretation solutions powered by Centrellis, GeneDx is positioned to be a powerful partner for BioPharma. Our team provides a suite of offerings and is constantly innovating to deliver unmatched value to ...
WebGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that Devin K. Schaffer has been appointed General Counsel, effective April 24, 2024. As a member of the executive leadership team, Devin will report directly to Katherine Stueland, President and CEO, and will be ... WebGeneDx offers a comprehensive menu of targeted variant testing options to meet the needs of families and healthcare providers. These tests are available for families who had previous testing at GeneDx as well as for families who had prior testing at another laboratory. Targeted variant testing is often ordered by healthcare providers in the ...
WebJan 18, 2024 · The CEO of GeneDx, Katherine Stueland, will become co-CEO of Sema4 alongside Sema4’s founder and leader Eric Schadt; and she’ll join Sema4’s board of directors. The latest move comes just six...
WebJan 20, 2024 · GeneDx still trains NIH fellows in genomics. Rubin said that GeneDx has essentially been run independently within BRL and Opko, other than sharing administrative support at the corporate level. The only key BRL executive moving to Sema4 will be CFO Kevin Feeley, according to Rubin. thunder cricket blue crawWebMay 23, 2016 · GeneDx University of Colorado, EMBA About Experienced healthcare leader with demonstrated excellence in the areas of product … thunder cricket swim jigWebGeneDx's key executives include Joy Adigun and 16 others. Joy Adigun Associate Director, Next Generation Sequencing Anne Maddalena Associate Director, Clinical Programs … thunder cricket bass proWebGeneDx New York, NY4 days agoBe among the first 25 applicantsSee who GeneDx has hired for this roleNo longer accepting applications. Location: Remote US. The Biopharma Commercial Lead is the ... thunder cricket fishing baitWebMay 4, 2024 · STAMFORD — Genomic-testing provider Sema4 announced this week the completion of its acquisition of another testing provider, GeneDx, whose chief executive officer will now lead Sema4. The new … thunder cricket jigWebSTAMFORD, Conn., April 03, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, … thunder cricket fishing lureWebSep 12, 2024 · Demonstrates Commitment to Scientific and Clinical Advancement with More Than 35 Poster and Podium Presentations. MIAMI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) (“OPKO” or “the Company”) announces that GeneDx will be showcasing its leadership in genetic and genomic testing with more than 35 … thunder cricket bladed jig